SARS-CoV-2 Membrane-, Envelope-, Nucleoprotein Protéine

N° du produit ABIN7538794

Protéine cVLP exprimée dans HEK-293 Cells.

Aperçu rapide pour SARS-CoV-2 Membrane-, Envelope-, Nucleoprotein Protéine (ABIN7538794)

Antigène: SARS-CoV-2 Membrane-, Envelope-, Nucleoprotein

Type de proteíne: cVLP

Origine: SARS Coronavirus-2 (SARS-CoV-2)

Source: HEK-293 Cells

Application: ELISA, Nanoparticle Tracking Analysis (NTA), Western Blotting (WB)

Détail du produit

Fonction: Chimeric VLP of SARS-CoV-2 (M+E+N) can be used as a control

Attributs du produit: Chimeric SARS-CoV-2 virus-like particles (cVLP) were produced in HEK cells by co-expression of the membrane-, envelope- and nucleoprotein with a membrane bound target protein. The VLPs do not contain the viral genome, cannot replicate and are not infectious.

Purification: Polyethylene glycol precipitation

Biological Activity Comment: active

Information d'application

Indications d'application: Applications: Immunogenic antigen, antigen for ELISA and Western blot.
Western blot: 1-10 μg, ELISA: 1-5 μg/mL

Commentaires:

Virus-like Particles are multiprotein complexes that resemble a native virus, but lack the genetic information. Therefore, VLPs are safe to handle in numerous fields of applications. For example, VLPs can be applied as antigen in serological assays (e.g. ELISA), or serve as reference material to standardize the performance of different diagnostic tests (e.g. rapid antigen tests or ELISA). Due to the self-adjuvanting properties of VLPs is the most common application of VLPs the use as antigen for immunizations for vaccine development or antibody discovery campaigns.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS

Stock: -80 °C

Stockage commentaire: - 80°C

Détail du antigène

Antigène: SARS-CoV-2 Membrane-, Envelope-, Nucleoprotein

Sujet: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus type 2) is a coronavirus (genus: Betacoronavirus, subgenus: Sarbecovirus) that was identified as the cause of COVID-19 disease in early 2020.